Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Pasmant

Showing results (81-90 of 124) with videos related to

Pageof 13
Sort By:
Journal of the National Cancer Institute|October 29, 2011
Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1Eric Pasmant, Audrey Sabbagh, Julien Masliah-Planchon, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 15, 2020
Identification of <i>TP53</i> mutated group using a molecular and immunohistochemical classification of endometrial carcinoma to improve prognostic evaluation for adjuvant treatmentsGuillaume Beinse, Bastien Rance, Pierre-Alexandre Just, et al.
Nature|August 15, 2014
PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapiesThomas De Raedt, Eline Beert, Eric Pasmant, et al.
Cancer Immunology Research|June 4, 2017
Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on <i>BRAF</i><sup>V600E</sup> Melanoma Lines with VemurafenibAlexandra Frazao, Marina Colombo, Emmanuelle Fourmentraux-Neves, et al.
Endocrine-Related Cancer|December 8, 2017
Detection and monitoring of circulating tumor DNA in adrenocortical carcinomaSimon Garinet, Juliette Nectoux, Mario Neou, et al.
Gynecologic Oncology|March 12, 2026
Peritoneal cancer risk after risk reducing salpingo-oophorectomy, impact of mutational status and STIC lesionsClaire Saule, Enora Laas, Nina Weber, et al.
Journal of Medical Genetics|September 29, 2023
Neurofibromatosis type 1 mosaicism in patients with constitutional mismatch repair deficiencyLéa Guerrini-Rousseau, Eric Pasmant, Martine Muleris, et al.
NPJ Genomic Medicine|September 8, 2024
Prenatal diagnosis for neurofibromatosis type 1 and the pitfalls of germline mosaicsLaurence Pacot, Dominique Vidaud, Manuela Ye, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 2018
Involvement of Aryl hydrocarbon receptor in myelination and in human nerve sheath tumorigenesisGhjuvan'Ghjacumu Shackleford, Nirmal Kumar Sampathkumar, Mehdi Hichor, et al.
The British Journal of Dermatology|October 13, 2023
Identification of potential common genetic modifiers of neurofibromas: a genome-wide association study in 1333 patients with neurofibromatosis type 1Laurence Pacot, Audrey Sabbagh, Pierre Sohier, et al.
Pageof 13

Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
Journal of the National Cancer Institute|October 29, 2011
Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1Eric Pasmant, Audrey Sabbagh, Julien Masliah-Planchon, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 15, 2020
Identification of <i>TP53</i> mutated group using a molecular and immunohistochemical classification of endometrial carcinoma to improve prognostic evaluation for adjuvant treatmentsGuillaume Beinse, Bastien Rance, Pierre-Alexandre Just, et al.
Nature|August 15, 2014
PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapiesThomas De Raedt, Eline Beert, Eric Pasmant, et al.
Cancer Immunology Research|June 4, 2017
Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on <i>BRAF</i><sup>V600E</sup> Melanoma Lines with VemurafenibAlexandra Frazao, Marina Colombo, Emmanuelle Fourmentraux-Neves, et al.
Endocrine-Related Cancer|December 8, 2017
Detection and monitoring of circulating tumor DNA in adrenocortical carcinomaSimon Garinet, Juliette Nectoux, Mario Neou, et al.
Gynecologic Oncology|March 12, 2026
Peritoneal cancer risk after risk reducing salpingo-oophorectomy, impact of mutational status and STIC lesionsClaire Saule, Enora Laas, Nina Weber, et al.
Journal of Medical Genetics|September 29, 2023
Neurofibromatosis type 1 mosaicism in patients with constitutional mismatch repair deficiencyLéa Guerrini-Rousseau, Eric Pasmant, Martine Muleris, et al.
NPJ Genomic Medicine|September 8, 2024
Prenatal diagnosis for neurofibromatosis type 1 and the pitfalls of germline mosaicsLaurence Pacot, Dominique Vidaud, Manuela Ye, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 2018
Involvement of Aryl hydrocarbon receptor in myelination and in human nerve sheath tumorigenesisGhjuvan'Ghjacumu Shackleford, Nirmal Kumar Sampathkumar, Mehdi Hichor, et al.
The British Journal of Dermatology|October 13, 2023
Identification of potential common genetic modifiers of neurofibromas: a genome-wide association study in 1333 patients with neurofibromatosis type 1Laurence Pacot, Audrey Sabbagh, Pierre Sohier, et al.
Pageof 13